Par Drugs & Chemicals Ltd (PAR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003142, "name": "Par Drugs & Che.", "stock_name": "Par Drugs & Che.", "full_name": "Par Drugs & Chemicals Ltd", "name_url": "stocks-analysis/par-drugs-che", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "84.94", "chg": -0.56, "chgp": "-0.65%", "dir": -1, "prev_price": "85.50", "mcapval": "107.00 Cr", "mcap": "Micro Cap", "scripcode": "", "symbol": "PAR", "ind_name": "Chemicals & Petrochemicals", "ind_code": 11, "indexname": "India SENSEX", "isin": "INE04LG01015", "curr_date": "May 20", "curr_time": "", "bse_nse_vol": 6904, "exc_status": "Active", "traded_date": "May 20, 2026", "traded_date_str": "2026 05 20", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/par-drugs-che-1003142-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Par Drugs & Chemicals Declines 7.22%: Quarterly Profit Drop and Market Reaction", "link": "https://www.marketsmojo.com/news/stocks-in-action/par-drugs-chemicals-declines-722-quarterly-profit-drop-and-market-reaction-3994203", "imagepath": "", "date": "2026-05-16 12:01:17", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>11 May:</strong> Stock opens at Rs.93.98, marginally down amid broad market weakness</p>\n <p><strong>12 May:</strong> Sharp 2.55% decline to Rs.91.58 as Sensex falls 2.19%</p>\n <p><strong>13 May:</strong> Partial recovery with 1.56% gain to Rs.93.01, Sensex up 0.32%</p>\n <p><strong>14 May:</strong> Slight dip to Rs.92.64 despite Sensex rising 1.01%</p>\n <p><strong>15 May:</strong> Heavy sell-off on quarterly results, stock plunges 5.78% to Rs.87.29</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class..." }, { "title": "Are Par Drugs & Chemicals Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-par-drugs-chemicals-ltd-latest-results-good-or-bad-3993369", "imagepath": "", "date": "2026-05-15 19:27:49", "description": "Par Drugs & Chemicals Ltd's latest financial results for the quarter ending March 2026 reveal significant operational challenges. The company reported a net profit of ₹0.85 crores, reflecting a substantial decline of 82.29% compared to the previous quarter. This marks a notable deterioration in profitability, as the latest net profit is also down 48.48% year-on-year.\n\nIn terms of revenue, the company generated net sales of ₹19.61 crores, which represents a 33.16% sequential decline and a 12.18% decrease compared to the same quarter last year. This decline in sales is particularly concerning as it is the lowest quarterly revenue figure in recent periods, suggesting potential issues with market demand or competitive positioning.\n\nThe operating margin has also faced significant compression, falling to 7.34% from 20.65% in the previous quarter. This sharp decline indicates heightened cost pressures or challenge..." }, { "title": "Par Drugs & Chemicals Q4 FY26: Sharp Profit Decline Raises Concerns Despite Strong Nine-Month Performance", "link": "https://www.marketsmojo.com/news/result-analysis/par-drugs-chemicals-q4-fy26-sharp-profit-decline-raises-concerns-despite-strong-nine-month-performance-3992865", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ParDrugsChemica_quaterlyResult_3992865.png", "date": "2026-05-15 11:49:18", "description": "Par Drugs & Chemicals Ltd., a Bhavnagar-based speciality chemicals manufacturer, reported a concerning fourth quarter for FY26, with net profit plunging 82.29% quarter-on-quarter to ₹0.85 crores from ₹4.80 crores in Q3 FY26. The sharp decline came despite the company maintaining a market capitalisation of ₹109.00 crores. The stock has reacted negatively to the results, trading at ₹88.30, down 4.68% and significantly below its 52-week high of ₹122.43." }, { "title": "Par Drugs & Chemicals Ltd Reports Sharp Decline in Quarterly Financial Performance Amid Negative Trend Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/par-drugs-chemicals-ltd-reports-sharp-decline-in-quarterly-financial-performance-amid-negative-trend-shift-3992741", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ParDrugsChemica_fintrenddot_3992741.png", "date": "2026-05-15 11:00:30", "description": "Par Drugs & Chemicals Ltd has reported a significant deterioration in its financial trend for the quarter ended March 2026, with key metrics such as net sales, operating profit, and earnings per share hitting multi-quarter lows. This reversal from a previously positive trajectory has prompted a downgrade in the company’s mojo grade to Sell, reflecting growing concerns over its near-term prospects amid a challenging industry backdrop." }, { "title": "Par Drugs & Chemicals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/par-drugs-chemicals-ltd-is-rated-hold-3983933", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ParDrugsChemica_mojoScore_3983933.png", "date": "2026-05-10 10:10:37", "description": "Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date perspective on its performance and outlook." }, { "title": "Par Drugs & Chemicals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/par-drugs-chemicals-ltd-is-rated-hold-3968050", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ParDrugsChemica_mojoScore_3968050.png", "date": "2026-04-29 10:10:36", "description": "Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 April 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 April 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Par Drugs & Chemicals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/par-drugs-chemicals-ltd-is-rated-hold-3951893", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ParDrugsChemica_mojoScore_3951893.png", "date": "2026-04-18 10:10:38", "description": "Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 April 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Par Drugs & Chemicals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/par-drugs-chemicals-ltd-is-rated-sell-3934859", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ParDrugsChemica_mojoScore_3934859.png", "date": "2026-04-07 10:10:45", "description": "Par Drugs & Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Par Drugs & Chemicals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/par-drugs-chemicals-ltd-is-rated-sell-3918843", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParDrugsChemica_mojoScore_3918843.png", "date": "2026-03-27 10:10:41", "description": "Par Drugs & Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook." } ], "total": 125, "sid": "1003142", "stock_news_url": "https://www.marketsmojo.com/news/par-drugs-chemicals-1003142" }, "announcements": [ { "details": "Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting held on November 11, 2019.", "source": "NSE", "caption": "Par Drugs And Chemicals Limited - Outcome of Board Meeting", "datetime": "13-Nov-2019" }, { "details": "Par Drugs And Chemicals Limited has informed the Exchange that the Company has fixed Record Date as November 25, 2019 for the purpose of INTERIM DIVIDEND", "source": "NSE", "caption": "Par Drugs And Chemicals Limited - Record Date", "datetime": "04-Nov-2019" }, { "details": "Par Drugs And Chemicals Limited has informed the Exchange regarding 'WHO-GMP Certification'.", "source": "NSE", "caption": "Par Drugs And Chemicals Limited - Updates", "datetime": "30-Oct-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Par Drugs & Chemicals Ltd has declared <strong>12%</strong> dividend, ex-date: 22 Nov 21", "dt": "2021-11-22", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Par Drugs & Chemicals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 27 Apr 21", "dt": "2021-04-27", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

11 May: Stock opens at Rs.93.98, marginally down amid broad market weakness

12 May: Sharp 2.55% decline to Rs.91.58 as Sensex falls 2.19%

13 May: Partial recovery with 1.56% gain to Rs.93.01, Sensex up 0.32%

14 May: Slight dip to Rs.92.64 despite Sensex rising 1.01%

15 May: Heavy sell-off on quarterly results, stock plunges 5.78% to Rs.87.29

Week Open

Read full news article

Are Par Drugs & Chemicals Ltd latest results good or bad?

2026-05-15 19:27:49

Par Drugs & Chemicals Ltd's latest financial results for the quarter ending March 2026 reveal significant operational challenges. The company reported a net profit of ₹0.85 crores, reflecting a substantial decline of 82.29% compared to the previous quarter. This marks a notable deterioration in profitability, as the latest net profit is also down 48.48% year-on-year. In terms of revenue, the company generated net sales of ₹19.61 crores, which represents a 33.16% sequential decline and a 12.18% decrease compared to the same quarter last year. This decline in sales is particularly concerning as it is the lowest quarterly revenue figure in recent periods, suggesting potential issues with market demand or competitive positioning. The operating margin has also faced significant compression, falling to 7.34% from 20.65% in the previous quarter. This sharp decline indicates heightened cost pressures or challenge...

Read full news article

Par Drugs & Chemicals Q4 FY26: Sharp Profit Decline Raises Concerns Despite Strong Nine-Month Performance

2026-05-15 11:49:18

Par Drugs & Chemicals Ltd., a Bhavnagar-based speciality chemicals manufacturer, reported a concerning fourth quarter for FY26, with net profit plunging 82.29% quarter-on-quarter to ₹0.85 crores from ₹4.80 crores in Q3 FY26. The sharp decline came despite the company maintaining a market capitalisation of ₹109.00 crores. The stock has reacted negatively to the results, trading at ₹88.30, down 4.68% and significantly below its 52-week high of ₹122.43.

Read full news article

Par Drugs & Chemicals Ltd Reports Sharp Decline in Quarterly Financial Performance Amid Negative Trend Shift

2026-05-15 11:00:30

Par Drugs & Chemicals Ltd has reported a significant deterioration in its financial trend for the quarter ended March 2026, with key metrics such as net sales, operating profit, and earnings per share hitting multi-quarter lows. This reversal from a previously positive trajectory has prompted a downgrade in the company’s mojo grade to Sell, reflecting growing concerns over its near-term prospects amid a challenging industry backdrop.

Read full news article

Par Drugs & Chemicals Ltd is Rated Hold

2026-05-10 10:10:37

Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date perspective on its performance and outlook.

Read full news article

Par Drugs & Chemicals Ltd is Rated Hold

2026-04-29 10:10:36

Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 April 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 April 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Par Drugs & Chemicals Ltd is Rated Hold

2026-04-18 10:10:38

Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Par Drugs & Chemicals Ltd is Rated Sell

2026-04-07 10:10:45

Par Drugs & Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Par Drugs & Chemicals Ltd is Rated Sell

2026-03-27 10:10:41

Par Drugs & Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article